Why Walt Disney Co (NYSE: DIS) Stock is a Buy

1869 8 0 0 0 0 (0)

Walt Disney Co (NYSE: DIS) just closed out fiscal 2018 with its strongest top-line growth in four years. Both the top-and bottom-line have never been higher. Walt Disney reported earnings of $1.48 per share on revenue of $14.3 billion. The consensus earnings estimate was $1.31 per share on revenue of $13.8 billion. Revenue grew 12.0% on a year-over-year basis. Let's look at a few reasons the well-oiled family-entertainment behemoth is a compelling stock to own. Walt Disney Co (NYSE: DIS) announced on Nov. 28 that it was increasing its semi-annual dividend by 4 cents a share to 88 cents with the January 2019 payment. As a result of the increase, it now pays out $1.76 annually, yielding 1.6%. 

Walt Disney Co (NYSE: DIS) put out the three of the biggest movies of 2017; Black PantherAvengers and Incredibles 2. Let’s also not forget that Disney has multiple revenue streams and looks ready to control a significant portion of what will soon be the last great hope for advertisers: live sports—via ESPN. Disney is also poised to close a $71.3 billion deal to acquire vital 21st Century Fox FOXA assets. Moreover, the company is set to have a 13% increase in free cash flow from $8.7 billion in 2017 to $9.8 billion in 2018. Again, like revenue and net income, this financial metric has never been higher. Disney's grooving again, and investors are starting to notice. 


 Over the past week, Walt Disney Co (NYSE: DIS) investment grade on the Hade Platform has risen steadily, making it a Top 30 stock. Ironically, this stability in overall rating happens during a time when the overall market is falling, and as our investment grades as an average have consistently declined for the last four months, effectively predicting a correction.

With overall investment grades still lower, we suggest holding large sums of cash and being very selective when making investment decisions. According to DIS stock’s current grade, it might very well be one of those selective opportunities. Why should you trust our ratings? The Hade Platform has proven over the course of three years through the application of DLAs and artificial intelligence that it consistently outperforms Wall Street consensus estimates (63%) and major benchmarks such as the S&P 500 (250%). Access our premium services and start beating the market.


Free users on Hade Platform can build a watchlist of stocks and access investment grades from our database of more than 4,000 securities. Premium members can access the platform to get an instant look at which stocks rate highest for value, growth, dividend, and which have the greatest short-term momentum, thereby allowing members to identify areas of opportunity. Premium services include interest trends, risk analysis, machine learning predictions, Top 100 stocks, MatriX Portfolio and more.

Register now for the world's best investment ideas



Comments (0)

Recent Updates

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Healthcare Total Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Consumer Helathcare Other of which Gold Bond Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Polio/Pertussis/Hib Vaccines (incl. Hexaxim/Hexyon, Pentacel, Pentaxim and Imovax) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Influenza Vaccines (incl. Vaxigrip, Fluzone HD, Fluzone, Flublok) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Meningitis/Pneumo Vaccines (incl. Menactra) Revenue

  •   
    Jan 19, 2019 9:38 AM

    Sanofi SA (ADR) - Vaccines Adult Booster Vaccines (incl. Adacel) Revenue